M&A Deal Summary

Confluent Medical Acquires Biomedical Structures

On August 9, 2016, Confluent Medical acquired medical products company Biomedical Structures from Ampersand Capital Partners and Symmetric Capital

Acquisition Highlights
  • This is Confluent Medical’s 3rd transaction in the Medical Products sector.
  • This is Confluent Medical’s 4th transaction in the United States.
  • This is Confluent Medical’s 1st transaction in Rhode Island.

M&A Deal Summary
Date 2016-08-09
Target Biomedical Structures
Sector Medical Products
Buyer(s) Confluent Medical
Sellers(s) Ampersand Capital Partners
Symmetric Capital
Deal Type Add-on Acquisition

Target

Biomedical Structures

Warwick, Rhode Island, United States
website
Biomedical Structures LLC is a developer and manufacturer of biomedical textile implants, while MPC focuses on the development and manufacturing of precise polymer components.

Search 192,907 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Confluent Medical

Scottsdale, Arizona, United States

website

Category Company
Founded 1991
Sector Medical Products
DESCRIPTION

Confluent Medical is a contract manufacturer of Nitinol-based and balloon catheter medical devices. Confluent provides a broad range of capabilities including developing and manufacturing components, delivery systems, and finished devices for medical device OEMs in many of the fastest-growing healthcare subsectors, including neurovascular, structural heart, electrophysiology, aortic intervention, peripheral vascular, and ENT. Confluent Medical was founded in 1991 and is based in Scottsdale, Arizona.

DEAL STATS #
Overall 4 of 7
Sector (Medical Products) 3 of 5
Type (Add-on Acquisition) 4 of 6
State (Rhode Island) 1 of 1
Country (United States) 4 of 6
Year (2016) 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2016-08-09 Modified Polymer Components

Sunnyvale, California, United States

Modified Polymer Components, Inc. is specializes in the design, development, and manufacture of highly precise polymer components and assemblies. MPC’s extensive production capabilities enable it to perform secondary operations for all types of polymer tubing, including complex multilumen extrusions, to create ramps, tips, and almost any imaginable feature.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2018-02-08 Corpus Medical

Campbell, California, United States

Corpus Medical, Inc. is a provider of high-quality consulting and manufacturing services for the development and commercialization of innovative intervention medical devices. Corpus Medical specializes in catheter technologies, assembly of fully packaged devices and medical implants. Corpus Medical was founded in 2009 and is based in Campbell, California.

Buy -

Seller(S) 2

SELLER

Ampersand Capital Partners

Wellesley, Massachusetts, United States

Investor Investor Investor Investor Investor

website

Category Growth Capital Firm
Founded 1988
PE ASSETS 2.0B USD
Size Large
Type Sector Focused
DESCRIPTION

Ampersand Capital Partners is a middle-market private equity group that concentrates on growth equity investment opportunities in the healthcare sector. The Firm looks to invest $10 to $100 million in businesses with $10 to $100 million of revenue. Specific areas of interests within healthcare include lab products, specialty diagnostic equipment, pharmaceutical outsourcing, and specialty pharma. Ampersand generally prefers to be the first and sole institutional investor. Ampersand was formed in 1988 and is based in Wellesley, Massachusetts.

DEAL STATS #
Overall 28 of 53
Sector (Medical Products) 8 of 14
Type (Add-on Acquisition) 20 of 38
State (Rhode Island) 1 of 1
Country (United States) 28 of 50
Year (2016) 6 of 9
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2016-08-09 Modified Polymer Components

Sunnyvale, California, United States

Modified Polymer Components, Inc. is specializes in the design, development, and manufacture of highly precise polymer components and assemblies. MPC’s extensive production capabilities enable it to perform secondary operations for all types of polymer tubing, including complex multilumen extrusions, to create ramps, tips, and almost any imaginable feature.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2016-08-22 BioClinica

Princeton, New Jersey, United States

Bioclinica is an integrated clinical life science solutions provider, delivering powerful insight into clinical trial development, assuring greater client success in bringing medical therapies to market, for people around the world. Through deep medical, scientific, and technology expertise, the company provides medical imaging and cardiac safety services; clinical adjudication; randomization and trial supply management and optimization; electronic and eSource data capture; site and patient payments; clinical trial management software; and drug safety solutions. Bioclinica’s global team of life science experts serves more than 500 pharmaceutical, biotechnology, and device organizations including the top 20 biopharmaceutical companies and leading CROs through offices in North America, Europe, and Asia. Bioclinica was formed in 1990 and is based in Princeton, New Jersey.

Sell -
SELLER

Symmetric Capital

Burlington, Massachusetts, United States

Investor Investor Investor

website

Category Private Equity Firm
Founded 2007
PE ASSETS 202M USD
Size Small
Type Sector Agnostic
DESCRIPTION

Symmetric Capital is a private equity firm that invests in profitable growth companies in the US and Canada. Symmetric seeks to invest $5 to $25 million to help fund shareholder liquidity needs, growth, acquisitions, or debt reduction. Symmetric will consider majority or minority positions and typically looks for market-leading companies owned by their founders, a family, or small partnership. Sectors of interest include business services, healthcare and life sciences, software, IT services, applied technology, industrial products, education, logistics and distribution, and consumer products. Symmetric was formed in 2007 and is based in Waltham, Massachusetts.

DEAL STATS #
Overall 12 of 14
Sector (Medical Products) 2 of 2
Type (Add-on Acquisition) 10 of 11
State (Rhode Island) 1 of 1
Country (United States) 11 of 13
Year (2016) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2015-04-01 BioRx

Cincinnati, Ohio, United States

BioRx LLC is a specialized pharmacy and infusion services provider that provides treatments for patients with ultra-orphan and rare, chronic diseases.

Sell $210M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2017-07-18 School Improvement Network

Midvale, Utah, United States

School Improvement Network is an online professional learning and teacher effectiveness company and partners with schools, districts, and educators throughout the United States, Canada, and overseas to increase student achievement.

Sell -
Mergr

Product

Company

Legal